A new report from the Institute for Clinical and Economic Review (ICER) in the US has found that the net prices of newly launched drugs rose 51% in a three-year period between 2022 and 2024, while the list prices rose 24%.The analysis also suggests that, had the 23 new medicines been launched at the prices […]
